Interactions of α-Melanotropin and Agouti on B16 Melanoma Cells: Evidence for Inverse Agonism of Agouti
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 17 (1-3) , 75-98
- https://doi.org/10.3109/10799899709036595
Abstract
Alpha-Melanocyte-stimulating hormone (alpha-MSH, alpha-melanotropin) and agouti control the switch between eumelanin and pheomelanin synthesis in mammalian melanocytes. Here we investigated interactions between alpha-MSH, agouti protein, cAMP elevating agents and phorbol ester on mouse B16 melanoma cells. Agouti (Kd 3.7 nmol/l) and alpha-MSH (Kd 2.3 nmol/l) had similar affinities to the MC1 melanocortin receptor. Both alpha-MSH and agouti induced MC1 receptor down-regulation. Agouti antagonized melanogenesis induced by alpha-MSH, forskolin, cholera toxin (CT), and pertussis toxin (PT). It also reduced the constitutive melanin formation of long-term cultures. Cell proliferation was inhibited by agouti (43% at 100 nM). This effect was reversed by alpha-MSH, forskolin, or CT. B16-G4F cells, a cell variant that lacks the MC1 receptor, did not respond to agouti. From these results we conclude that agouti shows the characteristics of an inverse agonist acting through the MC1 receptor.Keywords
This publication has 35 references indexed in Scilit:
- Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptorNature, 1994
- Colour-coded switchesNature, 1993
- Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor functionCell, 1993
- Molecular characterization of the mouse agouti locusCell, 1992
- Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNAFEBS Letters, 1992
- The Cloning of a Family of Genes That Encode the Melanocortin ReceptorsScience, 1992
- Cutaneous MelanomaNew England Journal of Medicine, 1991
- Growth factors in melanomaCancer and Metastasis Reviews, 1991
- Anchorage-independent growth of murine melanoma in serum-less media is dependent on insulin or melanocyte-stimulating hormoneExperimental Cell Research, 1985
- Inhibition of Clonogenic Growth of Melanoma Cells by Combination of Melanocyte Stimulating Hormone and TheophyllineJournal of Investigative Dermatology, 1981